PMC Links for Gene (Select 613) - PMC

Result Filters

Links from Gene

Items: 1 to 20 of 197

<< First< Prev

Page of 10

Next >Last >>

Select item 70630261.

Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia

Aparna Natarajan, Rajkumar Thangarajan, Sabitha Kesavan

Asian Pac J Cancer Prev. 2019; 20(11): 3399–3406. doi: 10.31557/APJCP.2019.20.11.3399

PMCID:: PMC7063026

Abstract Article PDF–752K

Select item 49165832.

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Jorge Cortes, Jeff H. Lipton, Delphine Rea, Raghunadharao Digumarti, Charles Chuah, Nisha Nanda, Annie-Claude Benichou, Adam R. Craig, Mauricette Michallet, Franck E. Nicolini, Hagop Kantarjian

Blood. 2012 Sep 27; 120(13): 2573–2580. Prepublished online 2012 Aug 15. doi: 10.1182/blood-2012-03-415307

PMCID:: PMC4916583

Abstract Article

Select item 46218063.

A Coiled-Coil Mimetic Intercepts BCR-ABL1 Dimerization in Native and Kinase-Mutant Chronic Myeloid Leukemia

David W. Woessner, Anna M. Eiring, Benjamin J. Bruno, Matthew S. Zabriskie, Kimberly R. Reynolds, Geoffrey D. Miller, Thomas O’Hare, Michael W. Deininger, Carol S. Lim

Leukemia. Author manuscript; available in PMC 2016 Feb 1.

Published in final edited form as: Leukemia. 2015 Aug; 29(8): 1668–1675. Published online 2015 Feb 27. doi: 10.1038/leu.2015.53

PMCID:: PMC4621806

Abstract Article PDF–916K

Select item 44423894.

Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Repress Breakpoint Cluster Region Protein Expression, Enhance Rac1 Activity, and Increase In Vitro Angiogenesis

Dhivya Ramalingam, Christine Happel, Joseph M. Ziegelbauer

J Virol. 2015 Apr 15; 89(8): 4249–4261. Published online 2015 Jan 28. doi: 10.1128/JVI.03687-14

PMCID:: PMC4442389

Abstract Article PDF–1.8M

Select item 41954455.

Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors

Elias Jabbour, Van Morris, Hagop Kantarjian, Cameron C. Yin, Elizabeth Burton, Jorge Cortes

Blood. 2012 Oct 18; 120(16): 3382–3383. doi: 10.1182/blood-2012-04-424192

Correction in:: Blood. 2013 Mar 7; 121(10): 1924.

PMCID:: PMC4195445

Article

Select item 40411986.

Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice

M Nieborowska-Skorska, G Hoser, A Hochhaus, T Stoklosa, T Skorski

Leukemia. Author manuscript; available in PMC 2014 Jun 2.

Published in final edited form as: Leukemia. 2013 Nov; 27(11): 2253–2254. Published online 2013 Apr 22. doi: 10.1038/leu.2013.123

PMCID:: PMC4041198

Article PDF–145K

Select item 36522767.

Tolerant Anti-insulin B Cells are Effective APCs

Peggy L. Kendall, James B. Case, Allison M. Sullivan, Jeff S. Holderness, K. Sam Wells, Edwin Liu, James W. Thomas

J Immunol. Author manuscript; available in PMC 2014 Mar 15.

Published in final edited form as: J Immunol. 2013 Mar 15; 190(6): 2519–2526. Published online 2013 Feb 8. doi: 10.4049/jimmunol.1202104

PMCID:: PMC3652276

Abstract Article PDF–2.2M

Select item 36466798.

Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia

Andrew M Stein, Giovanni Martinelli, Timothy P Hughes, Martin C Müller, Lan Beppu, Enrico Gottardi, Susan Branford, Simona Soverini, Richard C Woodman, Andreas Hochhaus, Dong-Wook Kim, Giuseppe Saglio, Jerald P Radich

BMC Cancer. 2013; 13: 173. Published online 2013 Apr 2. doi: 10.1186/1471-2407-13-173

PMCID:: PMC3646679

Abstract Article PDF–477K

Select item 35989419.

BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability

Artur Slupianek, Rafal Falinski, Pawel Znojek, Tomasz Stoklosa, Sylwia Flis, Valentina Doneddu, Dariusz Pytel, Ewelina Synowiec, Janusz Blasiak, Alfonso Bellacosa, Tomasz Skorski

Leukemia. Author manuscript; available in PMC 2013 Mar 15.

Published in final edited form as: Leukemia. 2013 Mar; 27(3): 629–634. Published online 2012 Oct 9. doi: 10.1038/leu.2012.294

PMCID:: PMC3598941

Abstract Article PDF–852K

Select item 340907410.

Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation

Naoto Takahashi, Masatomo Miura, Stuart A Scott, Takenori Niioka, Kenichi Sawada

J Hematol Oncol. 2012; 5: 23. Published online 2012 May 15. doi: 10.1186/1756-8722-5-23

PMCID:: PMC3409074

Abstract Article PDF–196K

Select item 304466811.

Bcr is a substrate for Transglutaminase 2 cross-linking activity

Sun-Ju Yi, John Groffen, Nora Heisterkamp

BMC Biochem. 2011; 12: 8. Published online 2011 Feb 10. doi: 10.1186/1471-2091-12-8

PMCID:: PMC3044668

Abstract Article PDF–1.2M

Select item 285718712.

Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia

Theo D. Kim, Seval Türkmen, Michaela Schwarz, Gökben Koca, Hendrik Nogai, Christiane Bommer, Bernd Dörken, Peter Daniel, Philipp le Coutre

Haematologica. 2010 Apr; 95(4): 582–588. Published online 2009 Dec 16. doi: 10.3324/haematol.2009.014712

PMCID:: PMC2857187

Abstract Article PDF–428K

Select item 283306813.

Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib

Michael Koldehoff, Lambros Kordelas, Dietrich W. Beelen, Ahmet H. Elmaagacli

Haematologica. 2010 Mar; 95(3): 388–397. doi: 10.3324/haematol.2009.016063

PMCID:: PMC2833068

Abstract Article PDF–320K

Select item 258576914.

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects

B Perazzona, H Lin, T Sun, Y Wang, R Arlinghaus

Oncogene. Author manuscript; available in PMC 2008 Nov 21.

Published in final edited form as: Oncogene. 2008 Apr 3; 27(15): 2208–2214. Published online 2007 Oct 15. doi: 10.1038/sj.onc.1210851

PMCID:: PMC2585769

Abstract Article PDF–1.6M

Select item 258576815.

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism

H Zhang, D Trachootham, W Lu, J Carew, FJ Giles, MJ Keating, RB Arlinghaus, P Huang

Leukemia. Author manuscript; available in PMC 2008 Nov 21.

Published in final edited form as: Leukemia. 2008 Jun; 22(6): 1191–1199. Published online 2008 Apr 3. doi: 10.1038/leu.2008.74

PMCID:: PMC2585768

Abstract Article PDF–821K

Select item 210006216.

Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia

Louise Southern, Jonathan Williams, Margaret M Esiri

BMC Neurol. 2007; 7: 35. Published online 2007 Oct 16. doi: 10.1186/1471-2377-7-35

PMCID:: PMC2100062

Abstract Article PDF–532K

Select item 189529317.

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

Jaspal Kaeda, Derville O'Shea, Richard M. Szydlo, Eduardo Olavarria, Francesco Dazzi, David Marin, Susan Saunders, Jamshid S. Khorashad, Nicholas C. P. Cross, John M. Goldman, Jane F. Apperley

Blood. 2006 May 15; 107(10): 4171–4176. Prepublished online 2006 Feb 7. doi: 10.1182/blood-2005-08-3320